Project Grant R01AR085576
- Carnegie Mellon University's Office of Sponsored Programs received $1,040,910 in Project Grant funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective April 1, 2026 through March 31, 2028. The award supports the development and clinical translation of a smart compression sleeve—a sensorized wearable garment embedding capacitive sensing technology—designed to...
- Grant Award Summary The University of Pittsburgh received a $299,992 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 30, 2025, with completion targeted for May 31, 2028. The project, "Quantifying the Mechanical Effects of Knee Bracing and Predicting Their Ability to Prevent Ligamentous Injury," will deliver research...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of California, San Diego a $675,131 Project Grant effective August 1, 2025, through June 30, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds research to develop ultrashort echo time (UTE) magnetic resonance imaging (MRI) techniques for early detection of knee osteoarthritis (OA). The project addresses...
- This Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop computational tools to accurately predict and interpret different patterns of knee pain in patients with osteoarthritis. The $348,680 award, with a period of performance from Sep 26, 2024 to Aug 31, 2026, will enable researchers at the University of Arizona to: 1) Adapt a...
- Federal Project Grant Award Summary Funding Agency & Program: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) Award Details: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received $869,364 in federal funding awarded on August 22, 2025, with a project completion date of June 30, 2030. This Project Grant supports fundamental research to define...
- Federal Project Grant Summary Award Details: The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a Project Grant of $206,250 to Massachusetts General Hospital (The General Hospital Corporation) on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project is scheduled for completion by May 31, 2029. Project Scope: This award funds the development and feasibility evaluation of an...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $361,300 exploratory/developmental Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective August 1, 2025 through July 31, 2027. The award supports research to identify novel signaling pathways and therapeutic targets for osteoarthritis (OA) disease...
- Federal Grant Award Summary Pennsylvania State University, operating as Penn State Milton S. Hershey Medical Center, received a $366,053 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award, dated June 1, 2026 with an ultimate completion date of May 31, 2028, supports research investigating the role of adrenergic receptor signaling and G-protein...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $1.2M Project Grant to the University of Delaware (September 24, 2025–August 31, 2030) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and validate next-generation magnetic resonance imaging (MRI) methods for detecting bone fracture healing problems. The research addresses a significant clinical gap: the current lack of reliable...
- Federal Project Grant Award Summary The University of Missouri at Kansas City received a $570,174 Project Grant award dated September 15, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This project, which extends through August 31, 2028, develops zonal-specific mineralized scaffolds designed to optimize osteochondral tissue regeneration by controlling collagen...
Summary Carnegie Mellon University received a $486,545 Project Grant award dated July 3, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The five-year project, extending through June 30, 2031, will develop and validate a novel in vivo cartilage mechanics assessment tool to enable earlier detection of knee osteoarthritis (OA). The research will systematically measure transient changes in cartilage deformation and composition (T2 relaxation time) across common activities including walking, standing, and supine positioning to establish task-dependent cartilage response profiles in both asymptomatic and OA-affected knees. The project comprises three integrated research aims: (1) investigating cartilage strain and composition recovery during active loading through walking to identify novel recovery mechanisms; (2) building a comprehensive reference dataset of healthy and OA joint responses during prolonged static loading and unloading conditions; and (3) comparing the diagnostic accuracy of in vivo cartilage mechanics against conventional imaging biomarkers. Upon completion, the research will deliver a clinically viable diagnostic tool that improves upon existing patient-reported outcomes and static imaging methods, ultimately supporting the development of chondroprotective physical therapy interventions for OA prevention and management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $486.5k | 7/7/26 |